Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
208.4 USD | -0.51% |
|
-2.84% | -11.84% |
06-17 | Charles River Laboratories, Captain T Cell Enter Manufacturing Deal | MT |
06-13 | Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.84% | 10.74B | |
+38.66% | 52.85B | |
-7.81% | 38.87B | |
+35.54% | 38.24B | |
-10.77% | 26.79B | |
+11.77% | 26.16B | |
-17.82% | 19.9B | |
+35.09% | 13.18B | |
+29.17% | 12.24B | |
-3.05% | 11.79B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Charles River Laboratories, Sanofi Collaborating to Develop Non-Animal Virtual Control Groups for Preclinical Trials